Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06914674
PHASE2

Tamoxifen for Advanced Solid Pseudopapillary Tumor of the Pancreas

Sponsor: Fudan University

View on ClinicalTrials.gov

Summary

Tamoxifen for Solid Pseudopapillary Tumor of the Pancreas

Key Details

Gender

All

Age Range

14 Years - 80 Years

Study Type

INTERVENTIONAL

Enrollment

30

Start Date

2025-03-20

Completion Date

2028-02-28

Last Updated

2025-04-06

Healthy Volunteers

No

Interventions

DRUG

Tamoxifen 20 mg

Tamoxifen: 10 mg orally twice daily. Combination therapy: Chemotherapy, radiotherapy, surgery, or other treatments per NCCN guidelines and patient condition.

Locations (1)

Shanghai Cancer Center

Shanghai, China